Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy
ChainCatcher reports that biopharmaceutical company Silo Pharma (NASDAQ: SILO) has announced the launch of a cryptocurrency fund management strategy and appointed crypto infrastructure expert Corwin Yu as the first member of its Cryptocurrency Advisory Board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bloomberg ETF Analyst: Doge ETF and XRP ETF Expected to Launch This Thursday

Data: Two whales withdrew 98.24 million MERL, worth approximately $14.9 million, from CEX in the past 6 days
The hacker who stole $300 million from an exchange's users sells 3,976 ETH
Trending news
MoreCrypto prices
More








